Literature DB >> 4546254

Receptor mobility and the mechanism of cell-cell binding induced by concanavalin A.

U Rutishauser, L Sachs.   

Abstract

The cell-cell binding induced by concanavalin A between single cells has been analyzed by use of cells attached to nylon fibers. Binding of a concanavalin A-coated cell to an untreated cell was found to a high degree between two lymphoma tumor cells, less frequently between a lymphoma cell and a normal lymphocyte, and only rarely between two normal lymphocytes. The binding was inhibited by the presence of a saccharide inhibitor of concanavalin A, but could not be reversed by addition of the inhibitor after the cells had bound to each other. Although no binding was obtained when both cells were coated with lectin or fixed with glutaraldehyde, fixation of a cell before coating with concanavalin A enhanced its ability to bind an untreated cell. The results indicate that cell-cell binding induced by concanavalin A requires short-range lateral movement of cell receptors for the lectin, that only one cell has to have mobile receptors, and that some receptors must be unoccupied by lectin molecules before cell-cell contact. Clustering of the receptors is not necessary and seems to hinder cell-cell binding. It is suggested that the short-range movement is required for alignment of individual receptors so as to form multi-point bridges between two cells by lectin molecules. The bridging is then followed by the formation of irreversible bonds between the cells. The receptors on tumor cells appear to have a greater ability than receptors on normal cells to align themselves for cell-cell binding.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4546254      PMCID: PMC388477          DOI: 10.1073/pnas.71.6.2456

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  A comparative evaluation of the distribution of concanavalin A-binding sites on the surfaces of normal, virally-transformed, and protease-treated fibroblasts.

Authors:  J Z Rosenblith; T E Ukena; H H Yin; R D Berlin; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

2.  The mechanism of cell fusion. I. Energy requirements for virus-induced fusion of Ehrlich ascites tumor cells.

Authors:  A Yanovsky; A Loyter
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

3.  Ligand-induced redistribution of concanavalin A receptors on normal, trypsinized and transformed fibroblasts.

Authors:  S De Petris; M C Raff; L Mallucci
Journal:  Nat New Biol       Date:  1973-08-29

4.  Temperature-dependent mobility of concanavalin A sites on tumour cell surfaces.

Authors:  G L Nicolson
Journal:  Nat New Biol       Date:  1973-06-13

5.  Inhibition of lectin agglutinability by fixation of the cell surface membrane.

Authors:  M Inbar; C Huet; A R Oseroff; H Ben-Bassat; L Sachs
Journal:  Biochim Biophys Acta       Date:  1973-07-18

6.  Mobility of carbohydrate containing sites on the surface membrane in relation to the control of cell growth.

Authors:  M Inbar; L Sachs
Journal:  FEBS Lett       Date:  1973-05-15       Impact factor: 4.124

7.  Cell fractionation and arrangement on fibers, beads, and surfaces.

Authors:  G M Edelman; U Rutishauser; C F Millette
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

8.  Specific fractionation of immune cell populations.

Authors:  U Rutishauser; C F Millette; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Membrane changes and adenosine triphosphate content in normal and malignant transformed cells.

Authors:  I Vlodavsky; M Inbar; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

10.  The relationship of concanavalin A binding to lectin-initiated cell agglutination.

Authors:  K D Noonan; M M Burger
Journal:  J Cell Biol       Date:  1973-10       Impact factor: 10.539

View more
  15 in total

1.  Receptor mobility and the binding of cells to lectin-coated fibers.

Authors:  U Rutishauser; L Sachs
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

Review 2.  Sponge cell aggregation.

Authors:  E G Müller; I Müller
Journal:  Mol Cell Biochem       Date:  1980-02-28       Impact factor: 3.396

3.  Receptor-mediated adhesion phenomena. Model studies with the Radical-Flow Detachment Assay.

Authors:  C Cozens-Roberts; J A Quinn; D A Lauffenberger
Journal:  Biophys J       Date:  1990-07       Impact factor: 4.033

4.  Sensitization of colicin K-treated bacteria by sodium dodecyl sulfate: presence of free colicin in colicin K-treated cultures of Escherichia coli.

Authors:  D Cavard
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

5.  Detection and separation of lymphocytes with specific surface receptors, by using microparticles.

Authors:  I Ljungsted; B Ekman; I Sjöholm
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857

6.  Mechanisms of adhesion among cells from neural tissues of the chick embryo.

Authors:  U Rutishauser; J P Thiery; R Brackenbury; B A Sela; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

7.  Concanavalin A potentiates syngeneic response in murine lymphocytes.

Authors:  K Ozato; J D Ebert
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

8.  The role of antigen mobility in anti-Rh0(D)-induced agglutination.

Authors:  E J Victoria; E A Muchmore; E J Sudora; S P Masouredis
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

9.  Binding of fluoresceinated lectins to normal and dinitrofluorobenzene treated human leucocytes.

Authors:  K R Madyastha; P R Madyastha; G W Wood
Journal:  Experientia       Date:  1978-10-15

10.  Membrane difference in peripheral blood lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin's disease.

Authors:  U Mintz; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.